SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-180918
Filing Date
2020-06-26
Accepted
2020-06-26 16:06:34
Documents
14
Period of Report
2020-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d942664d8k.htm   iXBRL 8-K 31231
2 EX-10.1 d942664dex101.htm EX-10.1 16050
6 GRAPHIC g942664g0624214322426.jpg GRAPHIC 4471
  Complete submission text file 0001193125-20-180918.txt   180843

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvta-20200626.xsd EX-101.SCH 3067
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20200626_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20200626_pre.xml EX-101.PRE 10951
11 EXTRACTED XBRL INSTANCE DOCUMENT d942664d8k_htm.xml XML 3273
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 20994183
SIC: 8071 Services-Medical Laboratories